Items

• Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. (2019-04)

  B. Stanetić, Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries., ATHEROSCLEROSIS, pp. 345 - 354, Apr, 2019

• THE ROLE OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN THE ASSESSMENT OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: RESULTS FROM SERBIAN UNIVERSITY PULMONARY EMBOLISM REGISTRY (SUPER). (2019-06)

  L. Kos, B. Stanetić, T. Kovačević-Preradović, M. Ostojic, THE ROLE OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN THE ASSESSMENT OF RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: RESULTS FROM SERBIAN UNIVERSITY PULMONARY EMBOLISM REGISTRY (SUPER)., Časopis udruženja pulmologa Republike Srpske, Vol. 9, No. 1-2, pp. 1 - 6, Jun, 2019

• How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2 diabetes? (2020-02)

  T. Kovačević-Preradović, Z. Zivanović, B. Stanetić, L. Kos, N. Sobot, S. Stojkovic, D. Uncanin, How would you treat: glucagon-like peptide 1 receptor analogue or sodium-glucose cotransporter 2 inhibitor in chronic coronary syndrome and heart failure in type 2 diabetes?, Srce i krvni sudovi, Vol. 39, No. 1, pp. 8 - 10, Feb, 2020

• Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery DiseasedA Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V (2020-02)

  B. Stanetić, Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery DiseasedA Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V, DIABETES CARE, Vol. 67, No. 2, pp. 15 - 25, Feb, 2020

• The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease (2021-04)

  B. Stanetić, The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease, GLOBAL HEART JOURNAL, Vol. 16, No. 1, pp. 22 - 27, Apr, 2021

• Prescribing pattern of benzodi- azepines in outpatients without a diagnosis of mental disorders - Retrospective study (2021-05)

  B. Stanetić, Prescribing pattern of benzodi- azepines in outpatients without a diagnosis of mental disorders - Retrospective study, Opšta medicina, Vol. 27, No. 2, pp. 1 - 10, May, 2021

• A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial (2021-05)

  B. Stanetić, A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial, EuroIntervention, Vol. 1, No. 17, pp. 0 - 10, May, 2021

• Effective therapeutic strategies for diabetic cardiomyopathy (2021-06)

  T. Kovačević-Preradović, B. Stanetić, Z. Zivanovic, L. Kos, N. Sobot, S. Stojkovic, D. Uncanin, Effective therapeutic strategies for diabetic cardiomyopathy, Srce i krvni sudovi, Vol. 40, No. 1, pp. 5 - 7, Jun, 2021

• Severe mitral regurgitation in a young patient - how would you treat? (2021-06)

  B. Stanetić, T. Kovačević-Preradović, L. Kos, Z. Zivanovic, M. Ostojic, Severe mitral regurgitation in a young patient - how would you treat?, Srce i krvni sudovi, Vol. 40, No. 1, pp. 12 - 14, Jun, 2021

• Effect of using HEART score in patients with chest pain at the emergency department of University Clinical Centre of the Republic of Srpska (2021-07)

  B. Stanetić, N. Jacimovic, S. Porcic, Effect of using HEART score in patients with chest pain at the emergency department of University Clinical Centre of the Republic of Srpska, BIOMEDICINSKA ISTRAŽIVANjA, Vol. 12, No. 1, pp. 1 - 8, Jul, 2021

• The Influence of Different Risk Factors on COVID-19 Outcomes in Adult Patients - An Observational-Descriptive Study (2021-11)

  B. Stanetić, The Influence of Different Risk Factors on COVID-19 Outcomes in Adult Patients - An Observational-Descriptive Study, Acta Medica Academica, Vol. 50, No. 2, pp. 308 - 316, Nov, 2021

• Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study (2022-06)

  B. Stanetić, Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study, GLOBAL HEART JOURNAL, Vol. 17, No. 1, pp. 40 - 50, Jun, 2022

• Assessment of Prognostic Markers of Heart Failure Following Acute Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention (2022-06)

  B. Stanetić, D. Marjanovic, J. Miljkovic, Assessment of Prognostic Markers of Heart Failure Following Acute Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention, SCRIPTA MEDICA, Vol. 53, No. 2, pp. 125 - 129, Jun, 2022

• Pericardial Effusion in Postcoronavirus Disease Patients with Preserved Ejection Fraction of the Left Ventricle and Normal Values of N-Terminal-Pro B-Type Natriuretic Peptide-Link with C-Reactive Protein and D-Dimer (2022-09)

  E. Begic, A. Iglica, R. Gojak, N. Naser, B. Stanetić, Pericardial Effusion in Postcoronavirus Disease Patients with Preserved Ejection Fraction of the Left Ventricle and Normal Values of N-Terminal-Pro B-Type Natriuretic Peptide-Link with C-Reactive Protein and D-Dimer, International Journal of Applied and Basic Medical Research, Vol. 12, No. 3, pp. 157 - 160, Sep, 2022

• Heat-not-burn tobacco products and cardiovascular risk reduction: A systematic review of randomized controlled trials (2023-01)

  E. Begic, B. Aziri, E. Omeragić, E. Medjedović, A. Iglica, B. Stanetić, T. Kovačević-Preradović, Z. Zivanović, A. Begić, S. Janković, N. Malčo, Z. Mladenović, A. Badnjević, Heat-not-burn tobacco products and cardiovascular risk reduction: A systematic review of randomized controlled trials, Technology and Health Care, pp. 9 - 18, Jan, 2023

• Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events (2023-03)

  B. Aziri, E. Begic, S. Janković, Z. Mladenović, B. Stanetić, T. Kovačević-Preradović, A. Iglica, A. Mujaković, Systematic review of sodium-glucose cotransporter 2 inhibitors: a hopeful prospect in tackling heart failure-related events, EUROPEAN JOURNAL OF HEART FAILURE, Mar, 2023

• SYNTAX SCORE II VERSION 2020: EXTERNAL VALIDATION OF PATIENTS TREATED BY CORONARY ARTERY BYPASS GRAFTING IN A SINGLE LARGE VOLUME CARDIO-SURGICAL CENTER (2023-03)

  B. Stanetić, SYNTAX SCORE II VERSION 2020: EXTERNAL VALIDATION OF PATIENTS TREATED BY CORONARY ARTERY BYPASS GRAFTING IN A SINGLE LARGE VOLUME CARDIO-SURGICAL CENTER, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 81, No. 8, Mar, 2023

• Sodium-glucose cotransporter-2 inhibitors: a swinging pendulum in the treatment of acute myocardial infarction (2023-05)

  B. Stanetić, Sodium-glucose cotransporter-2 inhibitors: a swinging pendulum in the treatment of acute myocardial infarction, MINERVA, May, 2023

• Diabetes, Migration, Nutrition. (2011-11)

  B. Stanetić, K. Schindler, B. Ludvik, Diabetes, Migration, Nutrition., Medical University of Vienna, Nov, 2011

• Uticaj glikoregulacije i dužine trajanja bolesti na pojavu depresije kod ispitanika sa tipom 2 dijabetesa (2012-09)

  S. Savić, K. Stanetić, G. Tešanović, B. Stanetić, Uticaj glikoregulacije i dužine trajanja bolesti na pojavu depresije kod ispitanika sa tipom 2 dijabetesa, Zbornik radova 2 Petog međunarodnog kongresa "Ekologija, zdravlje, rad i sport", pp. 358 - 364, Sep, 2012